AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12598392
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group received videotapes and a brochure designed to review skills for self control and treatment
Trial: 12598392
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received traditional treatment only
Trial: 7040657
Drug: Saline flush
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline flush following diazepam administration
Trial: 7040657
Drug: Barbotage (diluting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Barbotage (diluting the drug with the patient's own blood before injection)
Trial: 31035117
Drug: Vaginal progesterone
RxNorm normalized name: progesterone Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal progesterone gel (8%, 90 mg) once daily
Trial: 31035117
Drug: Intramuscular progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intramuscular progesterone (progesterone oil) once daily
Trial: 31035117
Drug: Vaginal progesterone
RxNorm normalized name: progesterone Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal progesterone gel and Intramuscular progesterone
Trial: 23830936
Drug: Once-weekly resistance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-weekly resistance training (1x RT)
Trial: 23830936
Drug: Twice-weekly resistance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly resistance training (2x RT)
Trial: 23830936
Drug: Twice-weekly balance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly balance and tone training (BAT)
Trial: 22137075
Drug: Clopidogrel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (75 mg/d) with cilostazol (200 mg/d) for 14 days (group 3)
Trial: 22137075
Drug: Clopidogrel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (75 mg/d) for 14 days (group 1)
Trial: 22137075
Drug: High-maintenance dose
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-maintenance dose of clopidogrel (150 mg/d) for 14 days (group 2)
Trial: 22137075
Drug: Clopidogrel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (75 mg/d) for 14 days (control group)
Trial: 17971943
Drug: Adefovir dipivoxil
RxNorm normalized name: Adefovir Dipivoxil
DrugBank: Adefovir dipivoxil (DB00718)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Adefovir dipivoxil (ADV) 10 mg/d for 48 weeks
Trial: 11791956
Drug: Sulfadoxine-pyrimethamine (SP)
RxNorm normalized name: pyrimethamine / sulfadoxine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfadoxine-pyrimethamine (SP) 25 mg/kg
Trial: 11791956
Drug: Mefloquine (MQ)
DrugBank: Mefloquine (DB00358)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mefloquine (MQ) 15 mg/kg
Trial: 20813217
Drug: MF59-adjuvanted influenza
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MF59-adjuvanted influenza vaccine
Trial: 10930676
Drug: Unadjuvanted subunit
RxNorm normalized name: covid-19, protein subunit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unadjuvanted subunit influenza vaccine
Trial: 9065352
Drug: Budesonide aqueous
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide aqueous nasal spray (256 micrograms/day)
Trial: 9065352
Drug: Budesonide aqueous
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide aqueous nasal spray (400 micrograms/day)
Trial: 8417382
Drug: No calcium-channel
RxNorm normalized name: Channel catfish
DrugBank: Channel catfish (DB15548)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No calcium-channel blocker
Trial: 22228743
Drug: α-lipoic acid
RxNorm normalized name: α-lipoic acid
DrugBank: Lipoic acid (DB00166)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: α-lipoic acid (ALA) 600 mg once daily for 5 weeks
Trial: 8926604
Drug: Drug trials
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug trials
Trial: 10487503
Drug: Troglitazone (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troglitazone (400 mg daily for 12 weeks)
Trial: 30236238
Drug: sugammadex 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sugammadex 4 mg kg‐1
Trial: 30236238
Drug: sugammadex 16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sugammadex 16 mg kg‐1
Trial: 17305661
Drug: Prednisolone 1
RxNorm normalized name: prednisolone 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone 1 mg/kg
Trial: 12728539
Drug: troglitazone 200
RxNorm normalized name: troglitazone 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: troglitazone 200 mg/day
Trial: 8741948
Drug: Alcohol pretreatment
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol pretreatment (0.5 g/kg and 1.0 g/kg)
Trial: 1414040
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg methotrexate (MTX) administered intramuscularly once a week
Trial: 1414040
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg gold sodium thiomalate (GST) administered intramuscularly once a week
Trial: 12207634
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg methotrexate (MTX)
Trial: 1749945
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg gold sodium thiomalate (GST)
Trial: 2580179
Drug: Captopril 25
RxNorm normalized name: captopril 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 25 mg + hydrochlorothiazide (HCTZ) 25 mg twice a day
Trial: 2580179
Drug: High-dose captopril
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose captopril (3 X 50-3 X 150 mg, mean = 325 +/- 87 mg/day) changed to low-dose captopril (2 X 50 mg, mean = 96 +/- 14 mg/day) in a fixed combination with 25 mg HCTZ
Trial: 29726361
Drug: 0.1% mometasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% mometasone furoate (MF) cream applied twice daily from day 1 of PMRT to 14 days after PMRT
Trial: 29726361
Drug: Eucerin Original
RxNorm normalized name: Eucerin Original Healing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eucerin Original (E) cream applied twice daily from day 1 of PMRT to 14 days after PMRT
Trial: 29726361
Drug: Eucerin Original
RxNorm normalized name: Eucerin Original Healing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eucerin Original (E) cream
Trial: 24932565
Drug: Marriage Checkup
RxNorm normalized name: Cardui Mariae Fructus
DrugBank: Milk thistle (DB14375)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marriage Checkup (MC) treatment
Trial: 10453872
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone for 3 months (20 mg/d for 8 weeks, 15 mg/d for 2 weeks, and 10 mg/d for 2 weeks) followed by inhaled budesonide (800 microg bid for 15 months)
Trial: 11796428
Drug: Placebo tablets
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablets followed by placebo inhaler therapy
Trial: 2334037
Drug: 16 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 16 ml/kg of Ringer's acetate solution immediately before spinal anaesthesia (Group A)
Trial: 2334037
Drug: 8 ml/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 ml/kg of Ringer's acetate solution immediately before spinal anaesthesia (Group B)
Trial: 498720
Drug: Smoking MH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smoking MH containing 7.5 mg (‐) delta‐9‐tetrahydrocannabinol
Trial: 31828315
Drug: Complete substitution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complete substitution of cigarettes with nicotine gum or lozenge (CS‐NRT)
Trial: 12860492
Drug: Fast-disintegrating oral
RxNorm normalized name: Fast Freeze
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fast-disintegrating oral risperidone tablet (0.5 mg)
Trial: 12860492
Drug: Conventional oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional oral risperidone tablet (0.5 mg)
Trial: 12860492
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (fast-disintegrating and conventional)
Trial: 10530501
Drug: Bio‐Quinone Q10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bio‐Quinone Q10 (100 mg) with Bio‐Antox (n = 13, group 2)
Trial: 8656146
Drug: Methimazole 10
RxNorm normalized name: methimazole 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methimazole 10 mg every 12th h
Trial: 8656146
Drug: Propylthiouracil 100
RxNorm normalized name: propylthiouracil 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propylthiouracil 100 mg every 12th h
Trial: 8656146
Drug: Methimazole 10
RxNorm normalized name: methimazole 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methimazole 10 mg every 8th h
Trial: 8656146
Drug: Propylthiouracil 100
RxNorm normalized name: propylthiouracil 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propylthiouracil 100 mg every 8th h
Trial: 8656146
Drug: Methimazole 10
RxNorm normalized name: methimazole 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methimazole 10 mg every 6th h
Trial: 8656146
Drug: Propylthiouracil 100
RxNorm normalized name: propylthiouracil 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propylthiouracil 100 mg every 6th h
Trial: 6509781
Drug: Low doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low doses of T3 therapy (20 micrograms twice a day)
Trial: 20807892
Drug: Once-weekly bortezomib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-weekly bortezomib
Trial: 20807892
Drug: Twice-weekly bortezomib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly bortezomib
Trial: 16342083
Drug: Isokinetic exercise,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isokinetic exercise, pulse ultrasound, and intraarticular hyaluronan therapy
Trial: 10400483
Drug: Aspirin intolerance
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin intolerance
Trial: 7759787
Drug: Clonidine (0.04
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (0.04 mg/m2 body surface twice daily for 12 months)
Trial: 321182
Drug: 1% chlorhexidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% chlorhexidine dental gel
Trial: 321182
Drug: Placebo quinine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo quinine sulfate-containing gel
Trial: 25770117
Drug: pCMV-vegf165 intramuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pCMV-vegf165 intramuscular injections (1.2 mg, 2 injections, 14 days apart) with standard pharmacological treatment
Trial: 25770117
Drug: pCMV-vegf165 intramuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pCMV-vegf165 intramuscular injections
Trial: 24187867
Drug: Basic treatment
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic treatment according to the Global Initiative for Asthma scheme
Trial: 17576863
Drug: Pulse steroids
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulse steroids in addition to standard intravenous immunoglobulin
Trial: 2607058
Drug: Methylphenidate (MPH)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPH) 5 mg, 10 mg, 15 mg, and 20 mg
Trial: 1110481
Drug: 5 per
RxNorm normalized name: 25 Person ANSI KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 per cent dextrose in normal saline infusions
Trial: 31015560
Drug: Placebo group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo group (verbal suggestion that treatment was effective)
Trial: 31015560
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (told that treatment was inert)
Trial: 21750358
Drug: HiToP (High
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HiToP (High Tone Power Therapy)
Trial: 18853250
Drug: Calcium plus
RxNorm normalized name: O Calcium Plus D
DrugBank: Cupric oxide (DB11134)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium plus vitamin D supplementation (500 mg of elemental calcium as calcium carbonate plus 200 IU of vitamin D(3) twice daily)
Trial: 18853250
Drug: Calcium plus
RxNorm normalized name: O Calcium Plus D
DrugBank: Cupric oxide (DB11134)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium plus vitamin D supplementation (1,000 mg of elemental calcium as calcium carbonate plus 400 IU of vitamin D(3) daily)
Trial: 23285154
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg oral doxycycline twice a day for 30 days
Trial: 16019766
Drug: EMLA cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA cream (local surface anesthesia)
Trial: 16019766
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream (control)
Trial: 12718836
Drug: GSK MMR
RxNorm normalized name: varicella-zoster virus vaccine live (Oka-Merck) strain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK MMR vaccine (three lots), 125 subjects each lot
Trial: 12718836
Drug: GSK MMR
RxNorm normalized name: varicella-zoster virus vaccine live (Oka-Merck) strain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK MMR vaccine
Trial: 12718836
Drug: Merck MMR
RxNorm normalized name: varicella-zoster virus vaccine live (Oka-Merck) strain Injection [Varivax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Merck MMR vaccine, 125 subjects
Trial: 12718836
Drug: GSK MMR
RxNorm normalized name: varicella-zoster virus vaccine live (Oka-Merck) strain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK MMR vaccine and Merck MMR vaccine
Trial: 9449500
Drug: Active challenge
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active challenge with a single-dose drink equivalent to 300 ml of cow's milk
Trial: 9449500
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (cow's milk)
Trial: 9449500
Drug: Both active
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both active and placebo treatments
Trial: 8595072
Drug: Percutaneous ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Percutaneous ibuprofen gel (500 mg, 10 g 5% gel on the back, area of 20 x 20 cm) with occlusion for 2 h
Trial: 8595072
Drug: Oral ibuprofen
RxNorm normalized name: ibuprofen Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ibuprofen tablet (400 mg)
Trial: 389050
Drug: LRH (Luteinizing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LRH (Luteinizing Hormone-Releasing Hormone)
Trial: 11811223
Drug: Cisapride 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 0.2 mg/kg (max 5mg/dose) plus MgO for 4 weeks
Trial: 11811223
Drug: Magnesium oxide
RxNorm normalized name: Magnesium Oxide
DrugBank: Magnesium oxide (DB01377)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Magnesium oxide (MgO) alone (125 mg three times a day for <20 kg or 250 mg three times a day for >20 kg)
Trial: 11811223
Drug: Cisapride 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 0.2 mg/kg (max 5mg/dose) plus MgO for 1 week
Trial: 30745518
Drug: Fosravuconazole (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosravuconazole (100 mg, orally once a day for 12 weeks)
Trial: 26209166
Drug: Eldecalcitol at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eldecalcitol at 0.75 μg/day and alendronate at 35 mg/week
Trial: 26209166
Drug: Alendronate at
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate at 35 mg/week
Trial: 25385669
Drug: Intramuscular progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intramuscular progesterone in oil (PIO)
Trial: 16319891
Drug: Salmeterol (long-acting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol (long-acting bronchodilator)
Trial: 16319891
Drug: Albuterol (short-acting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol (short-acting beta2-agonist bronchodilator)
Trial: 12487223
Drug: Fexofenadine 180
RxNorm normalized name: fexofenadine 180 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fexofenadine 180 mg orally daily for 1 week
Trial: 7628834
Drug: Diltiazem sustained-release
RxNorm normalized name: diltiazem
DrugBank: Diltiazem (DB00343)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diltiazem sustained-release (Mono-Tildiem LP 300 mg) with food intake
Trial: 7628834
Drug: Diltiazem sustained-release
RxNorm normalized name: diltiazem
DrugBank: Diltiazem (DB00343)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diltiazem sustained-release (Mono-Tildiem LP 300 mg) without food intake
Trial: 7628834
Drug: Diltiazem sustained-release
RxNorm normalized name: diltiazem
DrugBank: Diltiazem (DB00343)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diltiazem sustained-release (Mono-Tildiem LP 300 mg) at different times of administration
Trial: 3450519
Drug: Nifedipine therapy
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine therapy
Trial: 28559255
Drug: MHAB5553A (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MHAB5553A (120 mg)
Trial: 28559255
Drug: MHAB5553A (1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MHAB5553A (1,200 mg)
Trial: 28559255
Drug: MHAB5553A (3,600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MHAB5553A (3,600 mg)
Trial: 28559255
Drug: MHAB5553A (8,400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MHAB5553A (8,400 mg)
Trial: 28559255
Drug: MHAB5553A (10,800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MHAB5553A (10,800 mg)
Trial: 25062086
Drug: Myorelaxation Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myorelaxation Therapy (nocturnally applied non-occluding sublingual relaxation splint combined with daily stretching exercises)
Trial: 21774822
Drug: Atorvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (40 mg daily; n = 28)
Trial: 10563276
Drug: Experimental group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental group (0.3 cc metaproterenol in 2.5 cc of saline at times 0, 20", 40", 1', 2', 3', 4', 5', 6', and 7')
Trial: 8939269
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy (SLIT) with a solution of purified and biologically standardized extract of Parietaria judaica, following a preseasonal rush schedule.
Trial: 8939269
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (symptomatic drugs only)
Trial: 1767322
Drug: Cerebrolysin (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerebrolysin (15 ml of the drug in 200 ml of a 0.85% NaCl solution: 10 ml in the morning and 5 ml in the evening)
Trial: 1767322
Drug: Placebo (same
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (same amount of solution as cerebrolysin)
Trial: 25488963
Drug: Linifanib 17.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linifanib 17.5 mg once daily
Trial: 26931117
Drug: Sorafenib 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorafenib 400 mg twice daily
Trial: 23274057
Drug: Non-medical prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-medical prescription stimulants (NMPS)
Trial: 23274057
Drug: Non-medical prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-medical prescription stimulants (NMPS) with alcohol
Trial: 23274057
Drug: Past year
RxNorm normalized name: levonorgestrel
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Past year drinkers who did not use prescription stimulants
Trial: 23274057
Drug: Concurrent NMPS
RxNorm normalized name: NMP
DrugBank: Methyl pyrrolidone (DB12521)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent NMPS and alcohol users (use over the past year but not at the same time)
Trial: 13680313
Drug: Calcitriol, fluoride,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcitriol, fluoride, calcium, clodronate, etidronate, hormone replacement therapy, pamidronate, strontium, tiludronate, vitamin D
Trial: 10960802
Drug: Vinorelbine as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vinorelbine as a single agent
Trial: 25779885
Drug: No prophylactic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No prophylactic antibiotics (158 patients, 40.0%)
Trial: 23821974
Drug: Dexamethasone 10/5/5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 10/5/5 mg (immediately postoperatively and on day 1 and 2)
Trial: 23821974
Drug: Dexamethasone 20/10/10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 20/10/10 mg
Trial: 16283318
Drug: Amitriptyline (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (20 mg daily)
Trial: 12169073
Drug: Sertraline (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (50 to 200 mg/d for 24 weeks)